Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism
ByMICHELLE CHAPMAN AP business writer
September 23, 2025, 7: 49 AM
Shares of Tylenol maker Kenvue bounced back sharply before the opening bell Tuesday, a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism.
“Don’t take Tylenol,” Trump instructed pregnant women around a dozen times during the White House news conference Monday, also urging mothers not to give their infants the drug, known by the generic name acetaminophen in the U.S. or paracetamol in most other countries.
Shares of the New Jersey consumer brands company tumbled 7.5% Monday. Shares have regained most of those losses early Tuesday in premarket trading.
The announcement, which appeared to rely on existing studies rather than significant new research, arrives as Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine skeptic, advances the Make America Healthy Again movement that has focused on what it sees as potential causes of autism.
Kenvue disputed any link between the drug and autism this week and warned that if pregnant mothers don’t use Tyle